Tocotrienols are good adjuvants for developing cancer vaccines

BACKGROUND: Dendritic cells (DCs) have the potential for cancer immunotherapy due to their ability to process and present antigens to T-cells and also in stimulating immune responses. However, DC-based vaccines have only exhibited minimal effectiveness against established tumours in mice and humans....

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Hafid, Sitti Rahma, Radhakrishnan, Ammu Kutty, Nesaretnam, Kalanithi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824713/
https://www.ncbi.nlm.nih.gov/pubmed/20051142
http://dx.doi.org/10.1186/1471-2407-10-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824713/
https://www.ncbi.nlm.nih.gov/pubmed/20051142
http://dx.doi.org/10.1186/1471-2407-10-5

Ejemplares similares